The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission

Some chromosomal aberrations emerging in the course of treatment are probably not related to disease progression, but attribute to the germline alteration. Therefore, the dynamic genetic tests should be performed during the whole treatment process, which is significantly essential for efficacy evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yannan, Li, Chengwen, Zhao, Jiawei, Song, Yang, Wang, Juan, Mi, Yingchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628225/
https://www.ncbi.nlm.nih.gov/pubmed/29026552
http://dx.doi.org/10.1002/ccr3.1108
Descripción
Sumario:Some chromosomal aberrations emerging in the course of treatment are probably not related to disease progression, but attribute to the germline alteration. Therefore, the dynamic genetic tests should be performed during the whole treatment process, which is significantly essential for efficacy evaluation and treatment decision‐ making.

Ejemplares similares